January 12, 2026- Medtronic announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its MiniMed Go™ app. The MiniMed Go™ Smart Multiple Daily Injection (MDI) system seamlessly integrates the InPen™ smart insulin pen with the Instinct sensor made by Abbott — all connected through the MiniMed Go™ app. This powerful combination delivers real-time, personalized insights and actionable guidance, including:
- Missed dose alerts to help minimize glucose highs
- A dose calculator that simplifies dose decision-making
- Action-oriented guidance if a user misses or miscalculates a dose
- CareLink™ software reporting for easier provider collaboration
The MiniMed Go™ system is cleared for individuals with insulin-requiring type 1 and type 2 diabetes aged 7 years and older, as well as for children ages 2 to 6 years under the supervision of an adult caregiver. Compatibility of the Simplera™ sensor with MiniMed Go™ is currently under FDA review.